Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide at a medical spa has become one of the most searched phrases in UK weight-loss, yet the term covers very different things depending on where you are in the world. In the UK, semaglutide for weight management is sold under the brand name Wegovy and is a prescription-only medicine — meaning a qualified prescriber must assess you before any supply can happen, regardless of the setting. That single fact changes a great deal about how and where you can legally access it. This page walks through what the medical-spa model looks like in practice, how it compares to the regulated UK route, and what to look for to keep yourself safe.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In the United States, 'medical spas' (or medspas) are aesthetic clinics that often offer injectable treatments alongside wellness services — and since semaglutide became widely discussed, many began offering weight-loss injections as part of their menu. The phrase 'medical spa semaglutide' has followed that conversation across the Atlantic, so UK people searching it are usually asking one of two things: can I get semaglutide at a UK aesthetic or wellness clinic, and if so, how does that differ from a pharmacy or GP?
The honest answer is that the setting matters less than the oversight. Any UK clinic, spa, or online service that supplies semaglutide must do so through a licensed prescriber, using medicine sourced through the regulated UK supply chain. Semaglutide's clinical and regulatory background is the same wherever you receive it. What varies is the quality of the clinical review, the aftercare on offer, and whether the supply chain is genuinely authorised. Some UK aesthetic clinics do offer weight-loss prescriptions, and if you are researching specific branded formulations, it is worth understanding what Deus Medical semaglutide is and how it sits within the UK regulatory picture. The question to ask of any provider is the same: is the prescriber GPhC or GMC registered, can I verify the pharmacy, and is there clinical follow-up built in?
The MHRA has been clear that GLP-1 medicines are not assessed for quick or cosmetic weight loss, and a legitimate provider reflects that in how it assesses patients, looking at health, not just aesthetics.
A question our prescribers hear most weeks is whether a consultation at a beauty clinic or wellness centre is as thorough as one at a pharmacy or GP surgery. The answer depends entirely on the individual service, but the legal minimum is the same across the board.
Semaglutide is a prescription-only medicine under the Human Medicines Regulations 2012. That means a prescriber must take a clinical history, confirm your BMI meets the licensed threshold, rule out contraindications (such as a personal or family history of medullary thyroid carcinoma, or a history of pancreatitis), and review any other medicines you take. For women using oral contraceptives, relevant guidance also advises discussing contraception, since GLP-1 medicines can affect how quickly other medicines are absorbed. Repeat supplies require fresh clinical review, not an automatic renewal.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it arrives, a real clinician, not a screening algorithm. Identity is verified by photo ID, and weight is confirmed on a live video call. If you are transferring from another provider, your current treatment record is reviewed before any continuation. You can read more about what a clinically-led semaglutide service looks like and how it differs from less structured alternatives. The NHS England guidance on weight-management injections sets out clearly what responsible prescribing should involve.
One of the most important things to understand about semaglutide is that the medicine itself must come from the authorised UK supply chain. Wegovy is manufactured by Novo Nordisk; in the UK it is supplied as a pre-filled injection pen through licensed wholesale channels. A clinic or spa that cannot confirm the medicine's provenance (or that offers it at prices substantially below the market range) is a red flag worth taking seriously.
The MHRA has warned repeatedly about fake weight-loss pens circulating online and via social media. Some have contained entirely different medicines. Verifying any online pharmacy on the GPhC register takes about thirty seconds and is the single most reliable way to confirm legitimacy. If a clinic or website cannot point you to a registered pharmacy dispensing on its behalf, that is important information. Details about how legitimate semaglutide wholesale supply works and what separates it from unregulated channels may be useful if you are evaluating different providers.
Pricing context also helps. Since Eli Lilly raised Mounjaro's UK list price in September 2025, and with Wegovy similarly priced at the private market rate, legitimate monthly treatment typically falls in a range that reflects real pharmaceutical costs, professional fees, and dispensing overhead. If you are weighing up the total cost of private treatment, the Wegovy price guide covers what a transparent private prescription should include.
Semaglutide's side-effect profile is well-characterised from large clinical trials, including the STEP 1 study published in the New England Journal of Medicine, which followed nearly 2,000 adults over 68 weeks. The most common effects are gastrointestinal: nausea, loose stools, constipation, and indigestion are reported frequently, particularly in the early weeks of treatment or after a dose increase. For most people they settle; for some they persist and prompt a conversation about dosing pace.
Less common but more serious effects include symptoms of pancreatitis, severe stomach pain that spreads to the back, with or without vomiting, warrants urgent medical attention. Gallbladder problems and allergic reactions have also been reported. This is precisely why clinical review is built into responsible treatment: not as a formality, but because how you respond to the medicine matters and can change over time. A provider (whether a medical spa, a pharmacy, or a GP surgery) that does not offer structured follow-up is missing a core part of what makes GLP-1 treatment safe. If you have questions about ongoing support or want to understand eligibility in more detail, our FAQs cover the most common points, and our contact page connects you with the team.
If semaglutide sounds like it could be right for you, the next step is a clinical assessment rather than a booking at a wellness centre. Speak to our prescribers through a free consultation and find out whether treatment is appropriate for your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.